Antineoplaston researcher Burzynski indicted by federal grand jury on 75 fraud counts.
This article was originally published in The Tan Sheet
Executive Summary
ANTINEOPLASTON PROMOTER BURZYNSKI INDICTED BY HOUSTON FEDERAL GRAND JURY on 75 counts of mail fraud, contempt and FDA violations, Southern Texas U.S. Attorney Gaynelle Griffin Jones announced Nov. 20. Thirty-four counts of the federal indictment charge Houston physician Stanislaw Burzynski, MD, with mail fraud, while 40 counts cite him for introducing an unapproved drug into interstate commerce.